Crossmark

AI-powered medicine repurposed to identify new leishmaniasis treatments

Crossref DOI link: https://doi.org/10.1007/s12639-025-01838-8

Published Online: 2025-07-31

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Daungsupawong, Hinpetch https://orcid.org/0009-0002-5881-2709
Wiwanitkit, Viroj https://orcid.org/0000-0003-1039-3728
License Information

Text and Data Mining valid from 2025-07-31

Version of Record valid from 2025-07-31
More Information

Article History

Received: 30 September 2023

Accepted: 12 July 2025

First Online: 31 July 2025

Declarations

:

: The authors declare that they have no conflict of interest.